Search

Displaying results 7211 - 7220 of 8696 in total
  1. Drug

    Albuvirtide

    go.drugbank.com/drugs/DB15166
    Investigational

    Albuvirtide is under investigation in clinical trial NCT03719664 (Albuvirtide and 3BNC117 as Long-Acting Maintenance Therapy in Virologically Suppressed Subjects).

    Categories: Antivirals for Systemic Use, Antiinfectives for Systemic Use
  2. Drug

    RAF-265

    go.drugbank.com/drugs/DB05984
    Investigational

  3. Drug

    Velafermin

    go.drugbank.com/drugs/DB06493
    Investigational

    Velafermin was investigated as a potential therapy for the prevention and treatment of oral mucositis by fostering the regeneration and repair of the cells lining the gastrointestinal tract.

  4. Drug

    Pentaerithrityl

    go.drugbank.com/drugs/DB13526
    Investigational

    Categories: Drugs for Constipation
  5. Drug

    Carrimycin

    go.drugbank.com/drugs/DB16476
    Investigational

    Categories: Experimental Unapproved Treatments for COVID-19
  6. Drug

    AVR-RD-05

    go.drugbank.com/drugs/DB18631
    Experimental

    It is under investigation for the treatment of Hunter Syndrome (Mucopolysaccharidosis Type II, MPSII).

    Synonyms: Ex vivo, lentiviral vector (LV)-mediated, genetically modified autologous cell therapy intended for the stable provision of functional human iduronate-2-sulfatase (IDS) enzyme to subjects with Hunter syndrome
  7. Drug

    Stypocaulon scoparium

    go.drugbank.com/drugs/DB14260
    Investigational

    It is not an approved drug.

  8. Drug

    Arnica montana

    go.drugbank.com/drugs/DB14297
    Investigational

    It is not an approved drug.

  9. Drug

    Chicory leaf

    go.drugbank.com/drugs/DB14376
    Investigational

    It is not an approved drug.

  10. Drug

    PRX-OTC

    go.drugbank.com/drugs/DB17680
    Experimental

    PRX-OTC is an intracellular enzyme replacement therapy designed to replace missing or defective enzyme in patients with ornithine transcarbamylase deficiency.